<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>11</patient-age><report-id>PHHO2012TR003614</report-id><gender>male</gender><reactions><reaction>Macrophage activation syndrome</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>ACZ885 </drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Juvenile arthritis</indication></indications><patient-age>11</patient-age><outcomes><outcome>Life Threatening</outcome><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Turkey</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149690_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152631</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>6</safetyreportversion>
		<safetyreportid>PHHO2012TR003614</safetyreportid>
		<primarysourcecountry>TR</primarysourcecountry>
		<occurcountry>TR</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>2</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-03-01</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-22</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHO2012TR003614</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>Not Available</reporterfamilyname>
			<reportercountry>TR</reportercountry>
			<qualification code="1">Physician</qualification>
			<sponsorstudynumb>CACZ885G2301E1</sponsorstudynumb>
			<observestudytype>1</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientinvestigationnumb>202</patientinvestigationnumb>
			<patientonsetage>11</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>32</patientweight>
			<patientheight>136</patientheight>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pyrexia</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120227</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Pancytopenia</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20120229</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Aspiration bone marrow</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Macrophage activation syndrome</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Macrophage activation syndrome</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Histiocytosis haematophagic</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120229</reactionstartdate>
				<reactionfirsttime>92</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionlasttime>8</reactionlasttime>
				<reactionlasttimeunit>804</reactionlasttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<test>
				<testname>Alanine aminotransferase</testname>
				<hightestrange>less than 39</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Alanine aminotransferase</testname>
				<hightestrange>less than 39</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Aspartate aminotransferase</testname>
				<hightestrange>less than 51</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Aspiration bone marrow</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood creatinine</testname>
				<testresult>0.40</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>0.53</lowtestrange>
				<hightestrange>0.79</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Blood fibrinogen</testname>
				<lowtestrange>180</lowtestrange>
				<hightestrange>350</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood fibrinogen</testname>
				<testresult>206</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>219</lowtestrange>
				<hightestrange>403</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood lactate dehydrogenase</testname>
				<testresult>1206</testresult>
				<testunit>U/l</testunit>
				<hightestrange>less than 332</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Blood lactate dehydrogenase</testname>
				<testresult>560</testresult>
				<testunit>U/l</testunit>
				<hightestrange>less than 332</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testname>Blood triglycerides</testname>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Blood urea increased</testname>
				<lowtestrange>5</lowtestrange>
				<hightestrange>18</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Blood uric acid</testname>
				<testresult>1.26</testresult>
				<testunit>mg/dl</testunit>
				<lowtestrange>2.2</lowtestrange>
				<hightestrange>5.8</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120122</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120123</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>C-reactive protein</testname>
				<hightestrange>less than 0.3</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Cytomegalovirus test</testname>
				<lowtestrange>0</lowtestrange>
				<hightestrange>6.0</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Haematocrit</testname>
				<testresult>35.5</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Haematocrit</testname>
				<testresult>30.8</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Haematocrit</testname>
				<testresult>30.4</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Haematocrit</testname>
				<testresult>32.3</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Haematocrit</testname>
				<testresult>32.7</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Haematocrit</testname>
				<testresult>36.1</testresult>
				<testunit>%</testunit>
				<lowtestrange>39.5</lowtestrange>
				<hightestrange>50.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Haemoglobin</testname>
				<testresult>12.3</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.4</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Haemoglobin</testname>
				<testresult>10.8</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Haemoglobin</testname>
				<testresult>11.5</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Haemoglobin</testname>
				<testresult>11.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Haemoglobin</testname>
				<testresult>12.2</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>13.6</lowtestrange>
				<hightestrange>17</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23.7</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23.0</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>22.1</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>22.3</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>24</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Mean cell haemoglobin</testname>
				<testresult>23</testresult>
				<testunit>pg</testunit>
				<lowtestrange>27.2</lowtestrange>
				<hightestrange>33.5</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Mean cell volume</testname>
				<lowtestrange>80.7</lowtestrange>
				<hightestrange>95.5</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>150000</lowtestrange>
				<hightestrange>450000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>150000</lowtestrange>
				<hightestrange>450000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Platelet count</testname>
				<lowtestrange>156</lowtestrange>
				<hightestrange>373</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Platelet count</testname>
				<hightestrange>&gt;130000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Protein total</testname>
				<testresult>8.46</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>6.0</lowtestrange>
				<hightestrange>8.0</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Protein total</testname>
				<testresult>8.69</testresult>
				<testunit>g/dl</testunit>
				<lowtestrange>6.0</lowtestrange>
				<hightestrange>8.0</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Red blood cell sedimentation rate</testname>
				<hightestrange>less than 20 min/hr</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.9</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120303</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>19.2</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120304</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.9</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120305</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.3</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120308</testdate>
				<testname>Red cell distribution width</testname>
				<testresult>18.8</testresult>
				<testunit>%</testunit>
				<lowtestrange>11.8</lowtestrange>
				<hightestrange>14.3</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>636</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>864</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120302</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>583.6</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>Serum ferritin increased</testname>
				<testresult>155</testresult>
				<testunit>ng/ml</testunit>
				<lowtestrange>24</lowtestrange>
				<hightestrange>336</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120229</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120301</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120306</testdate>
				<testname>White blood cell count</testname>
				<lowtestrange>4000</lowtestrange>
				<hightestrange>105000</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.8</drugstructuredosagenumb>
				<drugstructuredosageunit code="012"/>
				<drugdosagetext>0.80 ml, UNK</drugdosagetext>
				<drugdosageform normalized="powder for sol for inj">Powder for sol for inj</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Juvenile arthritis</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-11-30</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.86</drugstructuredosagenumb>
				<drugstructuredosageunit code="012"/>
				<drugdosagetext>0.86 ml, UNK</drugdosagetext>
				<drugdosageform normalized="powder for sol for inj">Powder for sol for inj</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2011-12-26</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.85</drugstructuredosagenumb>
				<drugstructuredosageunit code="012"/>
				<drugdosagetext>0.85 ml, UNK</drugdosagetext>
				<drugdosageform normalized="powder for sol for inj">Powder for sol for inj</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-01-23</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>ACZ885 </medicinalproduct>
				<obtaindrugcountry>TR</obtaindrugcountry>
				<drugauthorizationnumb>BLA 125319</drugauthorizationnumb>
				<drugauthorizationcountry>TR</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>.88</drugstructuredosagenumb>
				<drugstructuredosageunit code="012"/>
				<drugdosagetext>0.88 ml, UNK</drugdosagetext>
				<drugdosageform normalized="powder for sol for inj">Powder for sol for inj</drugdosageform>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-02-22</drugstartdate>
				<drugstartperiod>92</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CANAKINUMAB</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Histiocytosis haematophagic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHO2012TR003614, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>report received on 01 Mar 2012, from clinical study CACZ885G2301E1. This 11-year old male subject (centre number 145, subject number 202) was enrolled in study protocol CACZ885G2301E1, an open label extension study of <Semaphore x="294710" class="Medicine" value="canakinumab" score="0.49" ID="290453">canakinumab </Semaphore>(ACZ885) in subjects with Systemic <Semaphore x="2084482" class="Disease or Finding" value="Juvenile Idiopathic Arthritis" score="1.00" ID="C114357">Juvenile Idiopathic Arthritis </Semaphore>(SJIA) and active systemic manifestations.The subject's medical history included <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever</Semaphore>. The subject does not have a history of autoinflammatory/autoimmune conditions, <Semaphore x="1907035" class="Disease or Finding" value="Exacerbation of cGVHD" score="1.00" ID="C103143">flaring </Semaphore>of the autoinflammatory/autoimmune condition during the <Semaphore x="1875899" class="Disease or Finding" value="Electrical Exposure" score="1.00" ID="C45407">current </Semaphore>event, previous <Semaphore x="3006761" class="MedDRA LLT" value="Histiocytosis haematophagic" score="1.00" ID="10048595"><Semaphore x="2148634" class="Disease or Finding" value="Macrophage Activation Syndrome" score="1.00" ID="C114471">macrophage activation <Semaphore x="2015478" class="Disease or Finding" value="Hemophagocytic Syndrome" score="1.00" ID="C35439">syndrome </Semaphore></Semaphore>
     <Semaphore x="3006761" class="MedDRA LLT" value="Histiocytosis haematophagic" score="1.00" ID="10048595">
      </Semaphore>
     <Semaphore x="2015478" class="Disease or Finding" value="Hemophagocytic Syndrome" score="1.00" ID="C35439">/ <Semaphore x="3006761" class="MedDRA LLT" value="Histiocytosis haematophagic" score="1.00" ID="10048595"><Semaphore x="2015456" class="Disease or Finding" value="Hemophagocytic Lymphohistiocytosis" score="1.00" ID="C34792">hemophagocytic </Semaphore>
       </Semaphore>
      <Semaphore x="2015456" class="Disease or Finding" value="Hemophagocytic Lymphohistiocytosis" score="1.00" ID="C34792">lymphohistiocytosis </Semaphore></Semaphore></Semaphore>and other medically significant chronic condition(s). The subject received open label study medication on 30 Nov 2011 at a dose of 0.80 ml. On 29 Feb 2012, the subject was hospitalised with the complaint of non remitting high <Semaphore x="1932946" class="Disease or Finding" value="Fever" score="1.00" ID="C3038">fever </Semaphore>of unknown etiology since 3 days. The subject does not present with <Semaphore x="2520936" class="Disease or Finding" value="Sign or Symptom" score="1.00" ID="C100104">signs or symptoms </Semaphore>like concurrent or recent <Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection</Semaphore>, <Semaphore x="3245054" class="MedDRA LLT" value="Sepsis" score="1.00" ID="10040047">sepsis</Semaphore>, liver/spleen <Semaphore x="3078455" class="MedDRA LLT" value="Lymphadenopathy" score="1.00" ID="10025197">enlargement, <Semaphore x="3078455" class="MedDRA LLT" value="Lymphadenopathy" score="1.00" ID="10025197">enlargement of the <Semaphore x="2135529" class="AnatomicStructure" value="Lymph Node Tissue" score="1.00" ID="C33034">lymph nodes</Semaphore></Semaphore></Semaphore>, hemorrhagic manifestations, <Semaphore x="1741104" class="AnatomicStructure" value="Central Nervous System" score="1.00" ID="C12438">CNS </Semaphore>dysfunction and other organ involvement (i.e., renal, <Semaphore x="2010398" class="AnatomicStructure" value="Heart" score="1.00" ID="C12727">cardiac</Semaphore>). It was noted that subject had <Semaphore x="2370819" class="Disease or Finding" value="Pancytopenia" score="1.00" ID="C34889">pancytopenia</Semaphore>. On 29 Feb 2012, the laboratory <Semaphore x="3049513" class="MedDRA LLT" value="Investigation" score="1.00" ID="10062026">investigation </Semaphore>revealed; <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">count </Semaphore>
    <Semaphore x="3189639" class="MedDRA LLT" value="Platelet count" score="1.00" ID="10035525">
     <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">1800(4000-105000, <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelets </Semaphore>count </Semaphore></Semaphore>84000 (150000-450000), <Semaphore x="1880224" class="Procedure" value="Electron Spin Resonance Spectroscopy" score="1.00" ID="C16534">ESR </Semaphore>(<Semaphore x="1896416" class="Procedure" value="Erythrocyte Sedimentation Rate Measurement" score="1.00" ID="C74611">erythrocyte sedimentation rate</Semaphore>); 26(&lt;20 min/hr), CRP(C reactive <Semaphore x="2433448" class="Procedure" value="Protein or Enzyme Type Measurement" score="0.90" ID="C64430">protein</Semaphore>) 16(&lt;8 mg/l), ferritin 636(24-336) and <Semaphore x="575965" class="Medicine" value="Fibrinogen" score="0.87" ID="268599">fibrinogen </Semaphore>320 (180-350). On 01 Mar 2012, the subject was transferred to another hospital. The subjectâ€™s underwent <Semaphore x="1880224" class="Procedure" value="Electron Spin Resonance Spectroscopy" score="1.00" ID="C16534">ESR</Semaphore>, <Semaphore x="2865160" class="MedDRA LLT" value="Coagulation factor" score="1.00" ID="10059744">coagulation factors </Semaphore>(i.e., <Semaphore x="575965" class="Medicine" value="Fibrinogen" score="0.87" ID="268599">fibrinogen</Semaphore>, etc), <Semaphore x="1849157" class="Procedure" value="Differential Leukocyte Count" score="1.00" ID="C98493"><Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">leukocyte </Semaphore>count, differential</Semaphore>, <Semaphore x="1653868" class="Procedure" value="C-Reactive Protein Measurement" score="1.00" ID="C64548">CRP</Semaphore>, <Semaphore x="2014841" class="Procedure" value="Hemoglobin Measurement" score="1.00" ID="C64848">hemoglobin</Semaphore>, <Semaphore x="2643734" class="Procedure" value="Triglyceride Measurement" score="1.00" ID="C64812">triglycerides</Semaphore>, ferritin, electrolytes, <Semaphore x="3189910" class="MedDRA LLT" value="Platelet function test" score="1.00" ID="10061684"><Semaphore x="2406396" class="Procedure" value="Platelet Aggregation Measurement" score="1.00" ID="C103427"><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951"><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelet </Semaphore>count</Semaphore>, <Semaphore x="2118991" class="Procedure" value="Liver Function Test" score="1.00" ID="C74954">liver function </Semaphore></Semaphore>
     <Semaphore x="3072840" class="MedDRA LLT" value="Liver function test" score="1.00" ID="10060105">
      <Semaphore x="2118991" class="Procedure" value="Liver Function Test" score="1.00" ID="C74954">tests </Semaphore></Semaphore></Semaphore>(<Semaphore x="2118991" class="Procedure" value="Liver Function Test" score="1.00" ID="C74954">Bilirubin</Semaphore>, <Semaphore x="1549211" class="Procedure" value="Aspartate Aminotransferase Measurement" score="1.00" ID="C64467">AST</Semaphore>, <Semaphore x="2118991" class="Procedure" value="Liver Function Test" score="1.00" ID="C74954">LFT</Semaphore>, AP, <Semaphore x="2092491" class="Procedure" value="Lactate Dehydrogenase Measurement" score="1.00" ID="C64855">LDH</Semaphore>, etc) and evidence of <Semaphore x="2015495" class="Disease or Finding" value="Hemophagocytosis" score="1.00" ID="C35985">hemophagocytosis </Semaphore>in the <Semaphore x="1614466" class="Disease or Finding" value="Bone Marrow Neoplasm" score="1.00" ID="C35370"><Semaphore x="1619584" class="AnatomicStructure" value="Bone" score="1.00" ID="C12366">bone </Semaphore>marrow </Semaphore>or other organ (i.e. <Semaphore x="2119807" class="AnatomicStructure" value="Liver" score="1.00" ID="C12392">liver</Semaphore>). On 01 Mar 2012 subject's <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>was 32000, <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelets </Semaphore>112000, '<Semaphore x="2092491" class="Procedure" value="Lactate Dehydrogenase Measurement" score="1.00" ID="C64855">LDH</Semaphore>' 1206, ferratin 864, <Semaphore x="575965" class="Medicine" value="Fibrinogen" score="0.87" ID="268599">fibrinogen </Semaphore>and on the same day, <Semaphore x="1613997" class="Procedure" value="Bone Marrow Aspiration" score="1.00" ID="C15644"><Semaphore x="1619584" class="AnatomicStructure" value="Bone" score="1.00" ID="C12366">bone </Semaphore>marrow aspiration </Semaphore>showed increased histocytes, hemophagotic cell and suggestive <Semaphore x="2148634" class="Disease or Finding" value="Macrophage Activation Syndrome" score="1.00" ID="C114471">MAS</Semaphore>. On 05 Mar 2012, <Semaphore x="1469106" class="Procedure" value="Alanine Aminotransferase Measurement" score="1.00" ID="C64433">ALT </Semaphore>was 20 (&lt; 39) and <Semaphore x="1549211" class="Procedure" value="Aspartate Aminotransferase Measurement" score="1.00" ID="C64467">AST </Semaphore>was 23 (&lt;51). On 06 Mar 2012, subject's <Semaphore x="2014841" class="Procedure" value="Hemoglobin Measurement" score="1.00" ID="C64848">hemoglobin </Semaphore>was 11.2 (13.6-17), <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore><Semaphore x="3189639" class="MedDRA LLT" value="Platelet count" score="1.00" ID="10035525">count </Semaphore>
    <Semaphore x="3189639" class="MedDRA LLT" value="Platelet count" score="1.00" ID="10035525">was 4600, thrombocyte count </Semaphore>98000(&gt; 130000), ferritin 155.The investigator reported that viral <Semaphore x="3245717" class="MedDRA LLT" value="Serology negative" score="1.00" ID="10050410">serology was <Semaphore x="2265745" class="Disease or Finding" value="Negative Patch Test" score="1.00" ID="C35633">negative </Semaphore></Semaphore>so <Semaphore x="2690730" class="Disease or Finding" value="Viral Infection" score="1.00" ID="C3439">viral infection </Semaphore>was ruled out. So the investigator <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>and provided the final event as <Semaphore x="2148634" class="Disease or Finding" value="Macrophage Activation Syndrome" score="1.00" ID="C114471">Macrophage Activation Syndrome</Semaphore>. Subject's <Semaphore x="2764325" class="MedDRA LLT" value="Aspiration bone marrow normal" score="1.00" ID="10003507"><Semaphore x="1613997" class="Procedure" value="Bone Marrow Aspiration" score="1.00" ID="C15644"><Semaphore x="1619584" class="AnatomicStructure" value="Bone" score="1.00" ID="C12366">bone </Semaphore>marrow aspiration </Semaphore><Semaphore x="1910095" class="Disease or Finding" value="Experimental Result" score="1.00" ID="C76125">results </Semaphore>were normal</Semaphore>. On an unknown date subject's <Semaphore x="1549211" class="Procedure" value="Aspartate Aminotransferase Measurement" score="1.00" ID="C64467">AST </Semaphore>(<Semaphore x="1549211" class="Procedure" value="Aspartate Aminotransferase Measurement" score="1.00" ID="C64467">Aspartate aminotransferase</Semaphore>) was 52, <Semaphore x="1469106" class="Procedure" value="Alanine Aminotransferase Measurement" score="1.00" ID="C64433">ALT </Semaphore>(<Semaphore x="1469106" class="Procedure" value="Alanine Aminotransferase Measurement" score="1.00" ID="C64433">Alanine aminotransferase</Semaphore>) was 14 and <Semaphore x="2818820" class="MedDRA LLT" value="Blood triglycerides normal" score="1.00" ID="10005840"><Semaphore x="2643734" class="Procedure" value="Triglyceride Measurement" score="1.00" ID="C64812">triglycerides </Semaphore>were normal</Semaphore>. The subject was treated with methyl <Semaphore x="1081881" class="Medicine" value="predniSONE" score="0.49" ID="291353">prednisone</Semaphore>, <Semaphore x="2048300" class="Procedure" value="Immunoscintigraphy" score="1.00" ID="C17436">immunomodulation </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>(<Semaphore x="423457" class="Medicine" value="cycloSPORINE" score="0.49" ID="243146">cyclosporine</Semaphore>) and IVIG <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Therapy</Semaphore>. There was no action taken with the study medication due to the events (<Semaphore x="2148634" class="Disease or Finding" value="Macrophage Activation Syndrome" score="1.00" ID="C114471">MAS </Semaphore>and <Semaphore x="2690730" class="Disease or Finding" value="Viral Infection" score="1.00" ID="C3439">viral infection</Semaphore>). At the time of the report, the subject was completely recovered from the event on an unknown date. These events were considered serious (<Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalisation</Semaphore>) by the investigator.The investigator reported that the events were suspected to be related to <Semaphore x="2394286" class="Procedure" value="Pharmacotherapy" score="1.00" ID="C15986">treatment with the study medication</Semaphore>.Follow up received on 02 Mar 2012, prior to the <Semaphore x="1607047" class="Disease or Finding" value="Blood Clot" score="1.00" ID="C27083">circulation </Semaphore>on the previous report: Updated information on events <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosis </Semaphore>with its causality <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome</Semaphore>.Follow up received on 06 Mar 2012: Updated information on laboratory <Semaphore x="3049513" class="MedDRA LLT" value="Investigation" score="1.00" ID="10062026">investigations </Semaphore>and final <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosis</Semaphore>.Follow up report received on 09 Mar 2012: Updated the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event as <Semaphore x="1803876" class="Disease or Finding" value="Complete Recovery" score="1.00" ID="C82467">complete recovery</Semaphore>.Follow up (checklist) received on 24 Dec 2012: Updated event verbatim, symptom of the event and laboratory <Semaphore x="3049513" class="MedDRA LLT" value="Investigation" score="1.00" ID="10062026">investigation</Semaphore>.Follow up <Semaphore x="2148634" class="Disease or Finding" value="Macrophage Activation Syndrome" score="1.00" ID="C114471">macrophage activation syndrome </Semaphore>checklist received on 10 Jan 2013: Updated medical history, symptoms, <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>medications and <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">laboratory reports</Semaphore>.Follow up report received on 22 Jan 2013: Updated the <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">laboratory reports</Semaphore>.</narrativeincludeclinical>
				<sendercomment>The reported serious adverse event MAS is expected as per current IB.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>